Elixinol Global Limited Annual Report 2020

Group Note 2020 $’000 2019 $’000 Restated Total comprehensive loss for the year is attributable to: Continuing operations 31 (31) Discontinued operations – 156 Non-controlling interest 31 125 Continuing operations (104,429) (78,866) Discontinued operations – (2,559) Owners of Elixinol Global Limited (104,429) (81,425) (104,398) (81,300) Note Cents Cents Restated Earnings per share for loss from continuing operations attributable to the owners of Elixinol Global Limited Basic loss per share 37 (58.23) (60.88) Diluted loss per share 37 (58.23) (60.88) Earnings per share for loss from discontinued operations attributable to the owners of Elixinol Global Limited Basic loss per share 37 – (1.94) Diluted loss per share 37 – (1.94) Earnings per share for loss attributable to the owners of Elixinol Global Limited Basic loss per share 37 (58.25) (62.71) Diluted loss per share 37 (58.25) (62.71) Comparative figures have been restated due to a prior year discontinued operation being reclassified as a continuing operation. Refer Note 9. The above consolidated statement of profit or loss and other comprehensive income should be read in conjunction with the accompanying notes Consolidated Statement of Profit or Loss and Other Comprehensive Income continued F INANCI AL REPORT Company Overview Financial Report Shareholder Information FY2020 Milestones 37 Strategy and Market Update